Webinars, Pharmaceutical

From Formulation to Patient – Intranasal Administration of CNS Therapeutics

CNS therapies are a well-defined target for drug repurposing for intranasal administration with a growing track record of success that includes commercialized products for treatment resistant depression and seizures.

This webinar examines the defining benefits of intranasal administration such as high patient acceptability, rapid onset, and the ability to deliver drugs to unconscious patients. The biology of drug delivery for CNS therapeutics is also explored with reference to the benefits of bypassing the blood brain barrier. Off-the-shelf devices for intranasal administration are reviewed and strategies for reformulation – powder or liquid – are considered.

The expert support available from Aptar Pharma, to support all aspects of drug reformulation for intranasal administration, are also discussed.

Watch the webinar
Author(s): Dr. Julie D. Suman
25 Feb 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

25 Apr 2022

Nasal Drug Development, Trends and Challenges with Nasal Formulat...

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
22 Apr 2022

Nose to Brain Drug Delivery – A Promising Future

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
21 Apr 2022

Nasal Drug Delivery, Trends, Challenges and Opportunities for The...

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
25 Feb 2022

From Formulation to Patient – Intranasal Administration of ...

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 13

Request Access

Close

Requesting access to From Formulation to Patient – Intranasal Administration of CNS Therapeutics.

  • This field is for validation purposes and should be left unchanged.
Back To Top